Objective. To compare health-related quality of life (HR-QOL), employment and disability of primary and secondary SS (pSS and sSS, respectively) patients with the general Dutch population. Methods. HR-QOL, employment and disability were assessed in SS patients regularly attending the University Medical Center Groningen (n ¼ 235). HR-QOL, employment and disability were evaluated with the Short Form-36 questionnaire (SF-36) and an employment and disability questionnaire. Results were compared with Dutch population data (matched for sex and age). Demographical and clinical data associated with HR-QOL, employment and disability were assessed. Results. Response rate was 83%. SS patients scored lower on HR-QOL than the general Dutch population. sSS patients scored lower on physical functioning, bodily pain and general health than pSS patients. Predictors for reduced HR-QOL were fatigue, tendomyalgia, articular involvement, use of artificial saliva, use of anti-depressants, comorbidity, male sex and eligibility for disability compensation (DC). Employment was lower and DC rates were higher in SS patients compared with the Dutch population. Conclusion. SS has a large impact on HR-QOL, employment and disability.
Introduction
SS is a chronic, systemic, lymphoproliferative autoimmune disease affecting the exocrine glands [1] . The salivary and lacrimal glands are most commonly affected, resulting in dry mouth and dry eyes. Extraglandular involvement can occur in SS, and includes, amongst others, pulmonary disease, renal disease and vasculitis. Moreover, almost all patients suffer from fatigue. SS can be primary (pSS) or secondary (sSS), the latter being associated with other autoimmune diseases such as RA or SLE. The estimated prevalence of SS in the general population is between 0.5 and 2%, which makes SS, after RA, the most common systemic autoimmune disease [2, 3] .
Rheumatological conditions have a major impact on patients. Apart from the symptoms mentioned above, patients may be restricted in their activities and their participation in society, resulting in a reduced health-related quality of life (HR-QOL) and an impaired socio-economic status. The latter may result in lower employment rates and more disability as compared with the general population [4] .
SS is known to affect patients' physical, psychological and social functioning [5] , but the impact of SS on HR-QOL, and especially on employment and disability, has not been studied extensively. Studies available are either performed in a small series of SS patients [6, 7] or aimed mainly at comparison with other rheumatic diseases [6] [7] [8] [9] , fatigue [9] and psychological status [8] , or at developing new tools for measuring fatigue and general discomfort in pSS patients [10] . Comparison between pSS and sSS has occasionally been described for HR-QOL [7, 9] , but not for employment and disability. The aim of this study was, therefore, to evaluate HR-QOL, employment and disability in a large cohort of Dutch SS patients, to relate outcomes to clinical and demographical data in this patient cohort, and to compare these data with those available for the general Dutch population. In addition, HR-QOL, employment and disability were compared between pSS and sSS patients, since it was hypothesized that the disease burden of sSS might differ from that of pSS due to co-existing auto-immune disease(s).
Patients and methods

Patients
SS patients (185 pSS and 50 sSS) regularly attending the Departments of Rheumatology, Clinical Immunology and Oral and Maxillofacial Surgery of the University Medical Center Groningen (UMCG), The Netherlands, were enrolled in this study. All patients were >18 years old and fulfilled the European-American criteria for SS [11] . All patients participating in this study were followed according to protocol, and, therefore, data on extraglandular manifestations (EGMs) were available for all patients. Ethical approval for this study was obtained from the local institutional review board (Medisch Ethische Toetsingscommissie of the University Medical Centre Groningen, The Netherlands).
Methods
Demographical and clinical data were obtained by chart review. EGMs were defined in accordance with previous studies [12, 13] . Tendomyalgia, skin involvement other than cutaneous vasculitis, oesophageal involvement, bladder involvement and thrombocytopenia are commonly observed symptoms and signs, and, thus, were also considered as EGMs. Moreover, at every visit the rheumatologists systematically evaluated the presence of EGMs.
Questionnaires were sent by regular mail to all patients. Six weeks after sending the questionnaires, patients who had not responded were approached by phone once, to ask for participation.
In the first questionnaire, patients were asked whether they suffered from arthralgia and/or tendomyalgia, fatigue, dry mouth and dry eyes. In addition, it asked which symptom they considered to be their most severe complaint.
To evaluate HR-QOL, a validated Dutch translation of the Short Form-36 (SF-36) was used [14] . The SF-36 is a questionnaire consisting of 36 items, with eight scales assessing two dimensions, viz. physical and mental health functioning. Scales and summary scores vary from 0 to 100, with 0 being the worst possible health status and 100 representing the best possible health status. The third questionnaire focused on level of education, employment and disability. In The Netherlands, an individual who is judged to be impaired by 580% is entitled to full disability compensation (DC). Individuals impaired by 15-80% are entitled to partial DC.
Age-and sex-matched data for the general Dutch population on the SF-36 were obtained from Aaronson et al. [14] . Data regarding employment and DC were obtained from the Dutch Office of Statistics (Centraal Bureau voor Statistiek, Voorburg, The Netherlands).
Statistical analysis
The t-tests and 2 tests were used for the comparison of demographical data, HR-QOL, employment and receiving DC between responders and non-responders, between pSS and sSS patients, and between SS patients and the general Dutch population. Alpha was set at 5%. Correlation between disease duration and HR-QOL was evaluated with a Pearson's correlation test.
To create effective models, univariate analyses were performed for each predictor variable on the outcomes (HR-QOL, employment and receiving DC). If variables were found to be significant, P-values were used in the further development of the model. Predictors with a P-value 40.2 were simultaneously entered into a multivariable model, after which backward elimination of predictors was used to remove non-significant predictors (P-value to remove >0.10). Subsequently, predictors not included in the multivariable model were entered to determine whether they could now enter the model, after which the procedure of backward elimination of predictors was repeated. Variables in the final models were tested for possible interactions. All analyses were carried out using SPSS for Windows version 16.0.
Results
Patient characteristics
A total of 196 patients (180 females, 16 males; mean age at diagnosis: 45.7 AE 15.7 years) responded to the mail survey (83%). One patient returned the questionnaire incompletely and was therefore excluded. The mean AE S.D. for age at the time of completing the questionnaire was 55.5 AE 15 years; the mean AE S.D. for disease duration was 9.7 AE 8.8 years. One hundred and fiftyfour (79%) patients were classified as pSS and 41 (21%) patients as sSS (Table 1) . Demographical data did neither differ between pSS and sSS patients nor between responders and non-responders.
The most frequently associated autoimmune disorders in sSS patients were SLE (46%) and RA (39%). Seventy-five (39%) patients suffered from at least one comorbid condition.
Artificial tears were used by 77% and anti-depressants by 9% of patients. NSAIDs, anti-malarial drugs and other immunosuppressants were used more frequently by sSS patients, whereas rituximab was more frequently prescribed for pSS patients.
EGMs were present in 185 (95%) patients. The main EGMs were articular involvement, RP and tendomyalgia. sSS patients suffered from articular and skin involvement more often than pSS patients. When restricting the EGMs to the EGMs defined in accordance with previous studies [12, 13] , EGMs occurred in 177 (91%) patients (pSS 137; sSS 40).
Current symptoms
Almost all patients suffered from dry mouth (n ¼ 183; 94%), dry eyes (n ¼ 183; 94%) and fatigue (n ¼ 166; 85%). Fatigue was the 
HR-QOL
When compared with the general Dutch population, HR-QOL was significantly decreased in SS patients as demonstrated by reduced SF-36 scores on six out of the eight scales and for the summary scores for physical and mental functioning ( Table 2) . sSS patients experienced a significantly lower HR-QOL than pSS patients on three of the four physical scales (physical functioning, bodily pain and general health); however, no differences were observed on the psychological scales. HR-QOL was comparable between sSS patients with either RA or SLE as the associated autoimmune disorder. Disease duration was not significantly correlated with any of the SF-36 scales. Highly educated patients scored significantly better on physical functioning (P ¼ 0.042) and mental health (P ¼ 0.005) compared with non-highly educated patients.
Multivariate regression analysis showed that fatigue, tendomyalgia, comorbidity, male sex and receiving DC were associated with a reduced physical component summary score (PCS) ( Table 3 ). Confounders were disease duration, use of NSAIDs and anti-depressants and employment. No significant effect modifiers (interaction terms) were found.
Multivariate regression analysis for the mental composite score (MCS) demonstrated that fatigue, articular involvement, use of artificial saliva, use of anti-depressants and comorbidity were associated with a reduced MCS, whereas dry mouth was associated with a higher MCS (Table 3) . Receiving DC was a confounding factor for the determinants in the primary model for the MCS. No effective modifiers were found.
Socio-economic status
A total of 135 (69%) patients were of working age (18-65 years) ( Table 4) . SS patients were significantly less often employed (P < 0.001), worked fewer hours (P ¼ 0.015) and were less frequently full time employed (P < 0.01), compared with the Dutch population. In detail, approximately half of the SS patients (n ¼ 69) had paid employment. Only seven (10%) SS patients worked full-time (536 h). On average, SS patients worked 21.7 AE 11.6 h/week. The mean sick leave was 15.6 AE 39 days during the past year (range 0-192 days). Highly educated patients were significantly more often employed than non-highly educated patients (P ¼ 0.001). No differences were found between pSS and sSS patients regarding employment variables.
Sixty-three (47%) working age patients received DC, because they were considered to be (partially) unfit for work (Table 4) . Twenty-eight (44%) of these patients were entitled to full DC. Moreover, 41 of the 63 (65%) patients receiving DC mentioned pSS, sSS or the associated rheumatic disease as the cause of receiving DC. No differences in DC were found between pSS and sSS patients or between highly educated and non-highly educated patients. A significantly higher percentage of SS patients received DC (47%) when compared with the general Dutch population (2%). Multivariate regression analysis for employment (Table 5) showed that a high level of education was associated with employment. Bladder involvement, use of oral moisturising gel, NSAIDs and oral corticosteroids, comorbidity and age at diagnosis were all negatively associated with employment. Autoimmune thyroiditis, use of artificial tears and age were confounding factors for these determinants. No interaction terms were found. Multivariate regression analysis for receiving DC (Table 5 ) demonstrated that the number of EGMs, use of artificial saliva and anti-malarial drugs, comorbidity, high level of education and male sex were associated with receiving DC. Age at diagnosis was negatively associated with receiving DC. Fatigue, skin involvement other than cutaneous vasculitis and use of pilocarpine were confounding factors for the determinants in the primary model for receiving DC. No interaction terms were found.
Discussion
This study shows that SS has a large impact on HR-QOL, employment and disability as reflected by lower SF-36 scores and employment rates, and higher disability rates when compared with the general Dutch population. Moreover, analysis of HR-QOL revealed that sSS patients were more limited in physical activities than pSS patients. Although the results are obtained in a Dutch cohort of SS patients, the striking differences in HR-QOL, employment and disability suggest that the results of our study are not limited to the Dutch population, but probably are generally applicable to SS patients when compared with healthy subjects.
Reduced HR-QOL in SS patients compared with normative data has been reported before, but these studies were performed in smaller populations [6, 9, 15] . Overall, the SF-36 scores for pSS patients in our study are comparable with those mentioned in earlier literature [8, 10, 15] .
We observed more limitations in physical functioning in sSS than in pSS patients. This is in contrast to the results described by Sutcliffe et al. [7] and Tensing et al. [9] . The latter studies were performed in smaller patient cohorts and mainly included sSS patients with SLE as second autoimmune disease. The associated rheumatic disease in our sSS patients was more diverse (RA, SLE and other). RA patients are considered to be more restricted in physical functioning than SLE patients [16] , which might explain the difference in results. We, however, did not observe such a difference between sSS/RA and sSS/SLE patients; perhaps because of the relatively small sSS subgroups in our study. In our regression analyses, several demographical and clinical factors were found to be associated with HR-QOL. The unexplained variance probably reflects unmeasured, non-diseaserelated psychosocial factors such as self-esteem, support and coping strategies [17] , and other factors such as immunological parameters, delay in diagnosis and untreated or undiagnosed depression [15] . Interestingly, fatigue was an important explanatory variable for reduced physical and mental HR-QOL. This finding is in agreement with other studies [5, 9, 18] . Furthermore, the importance of fatigue in SS was underscored by the fact that the majority of SS patients felt tired and 40% ranked fatigue as their most severe symptom. Fatigue should therefore be considered as an important treatment target.
Segal et al. [19] demonstrated that psychological variables such as depression are determinants for fatigue, but only partly account for it. Since depression could be of importance for our outcome measures as well, the use of anti-depressants was scored in our population (9%). The regression analyses showed that antidepressants were a predictive factor for mental HR-QOL, as can be expected; but not for physical HR-QOL, employment or receiving DC.
We observed low employment and high disability rates in SS, which also have been reported for rheumatic diseases such as RA [17, 20] and AS [17] . To our knowledge, these results have not previously been reported in SS patients.
A high level of education and comorbidity were the most significant predictors for having paid employment. One would expect, however, that fatigue and arthralgia would also have influenced the employment status. A possible explanation for the lack of this association could be that, with time, patients have gradually adapted their activities to these symptoms. This hypothesis is supported by the fact that only 10% of employed patients had a full-time job.
We found a higher frequency of EGMs (95%) compared with other studies [8, 12, 15] . This can partly be explained by the extended definition of EGM used in this study. Interestingly, we found a higher frequency of RP (43%), as compared with the study performed by Garcı´a-Carrasco et al. (16%) [12] . This may be explained by different weather circumstances in The Netherlands. The observed higher prevalence of lymphoproliferative disease (15 vs 2%) may be related to the use of parotid gland biopsies in the diagnostic work-up of our patients [21] . Parotid biopsies are more suited for (early) detection of lymphoproliferative disease than labial biopsies as mucosaassociated lymphoid tissue (MALT) and non-Hodgkin lymphomas are rarely found in labial glands.
Although the percentage of patients with EGMs did not differ between pSS and sSS patients, it should be noted that part of the EGM in sSS patients could be attributed to the associated autoimmune disease and not only to SS. EGMs and EGM-related treatment were predictive for HR-QOL, employment and receiving DC. Therefore, there is a need for accurate follow-up and treatment aimed at EGMs.
The response rate of 83% in our study is very reasonable. As such, the risk of a sampling bias of certain categories of patients to be preferentially included in this study is considered negligible. Furthermore, we did not observe any significant differences for age, sex and pSS/sSS ratio between responders and non-responders. We, therefore, conclude that our results are representative for SS patients regularly attending a medical centre specialized in SS patient care.
Since many SS patients suffer from reduced HR-QOL and are restricted in social and work-related activities, there is a great need for developing adequate treatment modalities to reduce SS-related complaints and to intervene in the progression of SS. Currently, no causal systemic treatment is available in SS and, therefore, only symptomatic treatment can be given. Recently, some studies reported good results of treatment with biologicals, especially anti-CD20 treatment [22] [23] [24] [25] . Therefore, further development and evaluation of systemic treatment options should be stimulated.
Conclusion
SS has a large impact on HR-QOL, employment and disability as reflected by lower SF-36 scores and employment rates, and higher disability rates in SS patients as compared with the general Dutch population. Several demographical and clinical factors were associated with HR-QOL, employment and receiving DC. Physical functioning, bodily pain and general health were worse in sSS than in pSS patients.
Rheumatology key messages
SS has a large impact on HR-QOL, employment and disability. sSS patients experience lower HR-QOL than pSS patients. Several demographical/clinical factors were associated with HR-QOL, employment and disability.
